Overview Study to Evaluate the Mass Balance and Biotransformation of [14C]-Fluzoparib in Chinese Patients With Solid Tumor Status: Completed Trial end date: 2019-12-24 Target enrollment: Participant gender: Summary Study to Evaluate the Mass Balance and Biotransformation of Single Dose [14C]-FZPL in Chinese Patients with Solid Tumor Phase: Phase 1 Details Lead Sponsor: Jiangsu HengRui Medicine Co., Ltd.